Unichem Laboratories Share Price

₹ 505.30

+₹1.45 (0.29%)
1D
Last updated 03 Nov, 2026, 13:06 IST
NSE: UNICHEMLAB
|
Pharmaceuticals

Unichem Laboratories Share Price Today

As of 3 Nov 2026, Unichem Laboratories share price is ₹505.30. The stock opened at ₹503.05, compared to its previous close of ₹503.85. During today's trading session, Unichem Laboratories share price moved in the range of ₹500.60 to ₹514.65, with an average price of ₹507.63 for the day. Looking at its last 52-week, the stock has touched a low of ₹278.20 and a high of ₹687.20. On the performance front, Unichem Laboratories share price has increased by 29.16% over the last six months and is up 6.99% on a year-on-year basis.

Share price over the last 1 day rose from 503.05 to 505.30, ranging between 500.80 and 513.15.
₹500.60
0.29% up today
₹514.65
1D LOW
1D HIGH

Unichem Laboratories Stock Insights

Latest Earning
Op Profit TrendUp by 160.72% QoQ
Latest Earning
Net Profit TrendUp by 280.11% QoQ
Latest Earning
Revenue TrendUp by 8.29% QoQ
Stock Performance
OutperformingBeat Nifty by 30.07 % in last 6 month
Shareholding Pattern
DIIDII decreased stake by 34.33%
Shareholding Pattern
FIIFII increased stake by 198.54%
Unichem Laboratories stock performance
Open₹503.05
High₹514.65
Low₹500.60
Prev. close₹503.85
Unichem Laboratories trading activity
Volume22,517
Average traded price₹508.38
Last traded time01:06:33 03 Nov
Last traded quantity3
Circuit
L
H
₹403.10
₹604.60
52-week
L
H
₹278.20
₹687.20
Mkt Cap Cr
3,549.51
P/E
11.17
P/B
1.25
ROA
8.15%
ROE
2.88%
ROCE
3.79%
Quick Ratio
1.38
EV/EBITDA
7.15

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Unichem Labs. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Unichem Labs. appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Unichem Labs. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Unichem Laboratories Company Background

ISIN
INE351A01035
Sector Market Cap
₹ 3,549.51 Cr

Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.

Unichem Laboratories Financial Highlights

  • Revenue: Unichem Laboratories reported revenue of ₹2,264.91 crore in FY26 vs ₹2,146.29 crore in FY25. It showed an increase of 5.53% on a yearly basis.
  • Operating Profit: Unichem Laboratories reported an operating profit of ₹292.38 crore in FY26 vs ₹154.59 crore in FY25. It showed an increase of 89.13% on a year-on-year basis.
  • Net Profit: Unichem Laboratories reported a net profit of ₹252.84 crore in FY26 vs ₹137.52 crore in FY25. It showed an increase of 83.86% on a yearly basis.

Unichem Laboratories Quarterly Result Highlights

  • Unichem Laboratories reported revenue of ₹648.23 crore in Jun 2026, compared with ₹598.59 crore in Mar 2026, representing an increase of 8.29% on a quarter-on-quarter (QoQ) basis.
  • Unichem Laboratories reported an operating profit of ₹48.99 crore in Jun 2026, compared with ₹18.79 crore in Mar 2026, representing an increase of 160.72% on a quarter-on-quarter (QoQ) basis.
  • Unichem Laboratories reported a profit of ₹41.47 crore in Jun 2026, compared with ₹10.91 crore in Mar 2026, reflecting an increase of 280.11% on a QoQ basis.
  • The earnings per share (EPS) of Unichem Laboratories stood at ₹35.91 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
70.22%
FII
2.70%
Other DII
0.75%
Retail and other
17.68%
Mutual funds
8.65%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.99%
Mar 20261.00%
Jun 20260.91%
Sep 20262.70%

Unichem Laboratories Investment Returns

1 day
+4.16%
1 week
+6.15%
1 month
-5.83%
1 year
+6.99%
3 years
+22.40%
5 years
+121.38%

Unichem Laboratories Share Price History

Unichem Laboratories share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹483.75 / ₹503.85
+4.16%
30 Oct 26
₹504.00 / ₹483.75
-4.20%
29 Oct 26
₹488.80 / ₹504.95
+3.30%
28 Oct 26
₹489.95 / ₹488.80
+1.60%
Show more

Unichem Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,201.85₹2,110.97₹1,785.11₹1,343.02
Other Income₹63.06₹35.32₹31.59₹38.52
Total Revenue₹2,264.91₹2,146.29₹1,816.70₹1,381.54
Total Expenses₹2,174.39₹1,991.70₹1,844.05₹1,519.33
Profit Before Tax₹292.38₹154.59-₹84.96-₹176.36
Tax₹39.54₹17.07₹8.80₹25.86
Profit After Tax₹252.84₹137.52-₹93.76-₹202.23
EPS - Basic₹35.91₹19.53-₹13.32-₹28.72
EPS - Diluted₹35.85₹19.47-₹13.32-₹28.72

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹292.38₹154.59-₹84.96-₹176.36
Income before WC changes₹219.34₹303.29₹112.36-₹43.52
Change in Assets-₹7.11-₹291.52-₹84.84-₹148.62
Change in Liabilities-₹201.02-₹2.37-₹7.15₹119.26
Change in WC-₹208.13-₹293.89-₹91.99-₹29.36
Cash flow from Operations₹3.64-₹7.02₹14.00-₹85.09
Cash flow from Investing₹192.06-₹241.23₹50.40₹202.81
Cash flow from Financing₹1.86₹183.76-₹106.31-₹81.30
Total Cash Flow₹197.56-₹64.49-₹41.91₹36.42
Cash (Start of the year)₹89.58₹154.75₹183.75₹109.20
Cash (End of the year)₹289.48₹89.58₹154.75₹183.75

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,540.10₹1,539.93₹1,531.63₹1,604.58
Current Assets₹2,197.34₹2,029.47₹1,743.32₹1,588.47
Total Assets₹3,737.44₹3,569.40₹3,274.95₹3,193.05
Current Liabilities₹885.94₹991.97₹737.60₹639.60
Net Current Asset₹1,311.40₹1,037.50₹1,005.72₹948.86
Non-Current Liabilities₹134.06₹126.84₹99.05₹118.14
Equity Capital₹2,717.44₹2,450.59₹2,438.30₹2,435.30
Total Equity & Liabilities₹3,737.44₹3,569.40₹3,274.95₹3,193.05

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,412.29₹1,735.70₹1,442.16₹1,072.43
Other Income₹62.90₹40.83₹30.39₹41.85
Total Revenue₹1,475.19₹1,776.53₹1,472.55₹1,114.28
Total Expenses₹1,492.76₹1,597.85₹1,507.12₹1,280.71
Profit Before Tax₹209.41₹182.68-₹92.18-₹279.09
Tax₹50.47₹19.72₹0.00₹20.61
Profit After Tax₹158.94₹162.96-₹92.18-₹299.70
EPS - Basic₹22.57₹23.15-₹13.09-₹42.57
EPS - Diluted₹22.53₹23.08-₹13.09-₹42.57

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹209.41₹182.68-₹92.18-₹279.09
Income before WC changes₹82.25₹289.98₹73.20-₹75.79
Change in Assets₹178.51-₹220.23-₹76.80-₹141.73
Change in Liabilities-₹208.50₹2.82-₹37.82₹100.28
Change in WC-₹29.99-₹217.41-₹114.62-₹41.45
Cash flow from Operations₹52.60₹72.29-₹41.57-₹117.33
Cash flow from Investing₹207.81-₹174.94₹53.24₹202.50
Cash flow from Financing-₹70.66₹38.26-₹48.06-₹61.76
Total Cash Flow₹189.75-₹64.39-₹36.39₹23.41
Cash (Start of the year)₹60.58₹125.65₹155.67₹94.13
Cash (End of the year)₹252.67₹60.58₹125.65₹155.67

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,558.80₹1,542.87₹1,457.57₹1,593.38
Current Assets₹1,533.65₹1,566.34₹1,383.94₹1,292.76
Total Assets₹3,092.45₹3,109.21₹2,841.51₹2,886.14
Current Liabilities₹314.96₹519.53₹465.75₹388.66
Net Current Asset₹1,218.69₹1,046.81₹918.19₹904.10
Non-Current Liabilities₹150.39₹129.93₹81.13₹113.21
Equity Capital₹2,627.10₹2,459.75₹2,294.63₹2,384.27
Total Equity & Liabilities₹3,092.45₹3,109.21₹2,841.51₹2,886.14
* All values are in INR Crore
Unichem Laboratories market depth
Bid quantityBid priceAsk priceAsk quantity
1505.7506.553
1505.65506.62
13505.6506.655
19505.55506.91
1505.35506.958
Total bid quantity35
Total ask quantity19
Unichem Laboratories technical summary
Bearish indicators4
Neutral indicators4
Bullish indicators0
OverallStrong Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
47.25
Neutral
ATR (14)
21.17
Neutral
STOCH(9,6)
79.8
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
27.97
Bearish
UO(9)
49.82
Neutral
ROC(12)
-3.02
Bearish
WillR(14)
-39.61
Neutral
Period
Simple value
Exponential vaue
5D
486.65
489.63
10D
491.36
494.85
20D
511.68
506.85
50D
530.06
518.13
100D
520.01
501.04
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Unichem Laboratories
Pharmaceuticals
Add Stock
Add Another

Unichem Laboratories Share Price FAQs

Please be aware that Unichem Laboratories stock prices are subject to continuous fluctuations due to various factors.